Back
Builders FirstSource, Inc. Vs. Avidity Biosciences, Inc. Industry Stock Comparison
Sell
46
BLDR
Builders FirstSource, Inc.
Last Price:
$110.02
Seasonality Move:
13.36%
Buy
70
RNA
Avidity Biosciences, Inc.
Last Price:
$71.65
Seasonality Move:
32.33%
Sell
46
Builders FirstSource, Inc. (BLDR)
is a Sell
Is Builders FirstSource, Inc. a Buy, Sell or Hold?
-
The current Builders FirstSource, Inc. [BLDR] share price is $110.01. The Score for BLDR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
BLDR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Avidity Biosciences, Inc. (RNA)
is a Buy
Is Avidity Biosciences, Inc. a Buy, Sell or Hold?
-
The current Avidity Biosciences, Inc. [RNA] share price is $71.63. The Score for RNA is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
RNA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BLDR Stock Price Chart
What is Builders FirstSource, Inc.'s stock price today?
-
The Builders FirstSource, Inc. share price today is $110.01The current trend is relatively stagnant and BLDR is experiencing selling pressure, which indicates risk of future bearish movement.
RNA Stock Price Chart
What is Avidity Biosciences, Inc.'s stock price today?
-
The Avidity Biosciences, Inc. share price today is $71.63Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
BLDR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.79 | Sell |
| Relative Strength Index (14 RSI): | 49.57 | Sell |
| Chaikin Money Flow: | -1775334 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101.42 - 113.08) | Buy |
| Bollinger Bands (100): | (111.96 - 137.62) | Sell |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.69 | Buy |
| Relative Strength Index (14 RSI): | 77.36 | Buy |
| Chaikin Money Flow: | -1446313 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.09 - 71.45) | Buy |
| Bollinger Bands (100): | (38.74 - 64.48) | Buy |
BLDR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 111.71 | Sell |
| 20-day SMA: | 106.08 | Buy |
| 50-day SMA: | 115.32 | Sell |
| 200-day SMA: | 123.12 | Sell |
| 8-day EMA: | 110.19 | Sell |
| 20-day EMA: | 109.29 | Buy |
| 50-day EMA: | 114.34 | Sell |
| 200-day EMA: | 127.43 | Sell |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.56 | Buy |
| 20-day SMA: | 71.01 | Buy |
| 50-day SMA: | 60.81 | Buy |
| 200-day SMA: | 40.9 | Buy |
| 8-day EMA: | 71.44 | Buy |
| 20-day EMA: | 69.83 | Buy |
| 50-day EMA: | 62.78 | Buy |
| 200-day EMA: | 46.45 | Buy |
Builders FirstSource, Inc. Earnings Growth & BLDR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.40 per share, and a decrease next year of $0.58 per share.
Avidity Biosciences, Inc. Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.63 per share, and a decrease next year of $0.41 per share.
Builders FirstSource, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||